Lack of Duffy antigen expression is associated with organ damage in patients with sickle cell disease

Transfusion

Volumn 48, Issue 5, 2008, Pages 917-924

  Afenyi Annan, Araba ^a   Kail, Melanie ^b   Combs, Martha R ^b   Orringer, Eugene P ^b   Ashley Koch, Allison ^b   Telen, Marilyn J ^b  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BLOOD GROUP ANTIGEN; CYTOKINE; DUFFY ANTIGEN; GLYCOPROTEIN; HEMOGLOBIN S; HYDROXYUREA;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP DUFFY SYSTEM; BLOOD VESSEL OCCLUSION; CLINICAL ASSESSMENT; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; ERYTHROCYTE; FEMALE; GENOTYPE; HUMAN; KIDNEY DYSFUNCTION; LABORATORY TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; ORGAN INJURY; PROGNOSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEINURIA; SICKLE CELL ANEMIA;

ADOLESCENT; ADULT; AGED; ANEMIA, SICKLE CELL; DUFFY BLOOD-GROUP SYSTEM; ERYTHROCYTES; FEMALE; GENE EXPRESSION; GENETIC MARKERS; GENOTYPE; HUMANS; KIDNEY DISEASES; LEUKOCYTE COUNT; LOGISTIC MODELS; LUNG DISEASES; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PHENOTYPE; RECEPTORS, CELL SURFACE; SEVERITY OF ILLNESS INDEX;

EID: 42949086836     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01622.x     Document Type: Article

References (46)

1. Jison ML, Munson PJ, Barb JJ, Suffredini AF, Talwar S, Logun C, Raghavachari N, Beigel JH, Shelhamer JH, Danner RL, Gladwin ML. Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood 2004 104 : 270 80.
2. Makis AC, Hatzimichael EC, Bourantas KL. The role of cytokines in sickle cell disease. Ann Hematol 2000 79 : 407 13.
3. Platt OS. Sickle cell anemia as an inflammatory disease. J Clin Invest 2000 106 : 337 8.
4. Kaul DK, Hebbel RP. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest 2000 106 : 411 20.
5. Hebbel RP. Adhesive interactions of sickle erythrocytes with endothelium. J Clin Invest 1997 100 (11 Suppl S83 6.
6. Osarogiagbon UR, Choong S, Belcher JD, Vercellotti G, Paller MS, Hebbel RP. Reperfusion injury pathophysiology in sickle transgenic mice. Blood 2000 96 : 314 20.
7. Belcher JD, Bryant CJ, Nguyen J, Bowlin PR, Kielbik MC, Bischof JC, Hebbel RP, Vercellotti GM. Transgenic sickle mice have vascular inflammation. Blood 2003 101 : 3953 9.
8. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994 330 : 1639 44.
9. Hebbel RP, Schwartz RS, Mohandas N. The adhesive sickle erythrocyte: cause and consequence of abnormal interactions with endothelium, monocytes/macrophages and model membranes. Clin Haematol 1985 14 : 141 61.
10. Ataga KI, Orringer EP. Hypercoagulability in sickle cell disease: a curious paradox. Am J Med 2003 115 : 721 8.
11. Hoppe C, Klitz W, Cheng S, Apple R, Steiner L, Robles L, Girard T, Vichinsky E, Styles L. Gene interactions and stroke risk in children with sickle cell anemia. Blood 2004 103 : 2391 6.
12. Adams GT, Snieder H, McKie VC, Clair B, Brambilla D, Adams RJ, Kutlar F, Kutlar A. Genetic risk factors for cerebrovascular disease in children with sickle cell disease: design of a case-control association study and genomewide screen. BMC Med Genet 2003 4 : 6.
13. Castro V, Alberto FL, Costa RN, Lepikson-Neto J, Gualandro SF, Figueiredo MS, Annichino-Bizzacchi JM, Saad ST, Costa FF. Polymorphism of the human platelet antigen-5 system is a risk factor for occlusive vascular complications in patients with sickle cell anemia. Vox Sang 2004 87 : 118 23.
14. Chaar V, Tarer V, Etienne-Julan M, Diara JP, Elion J, Romana M. ET-1 and ecNOS gene polymorphisms and susceptibility to acute chest syndrome and painful vaso-occlusive crises in children with sickle cell anemia. Haematologica 2006 91 : 1277 8.
15. Nolan VG, Baldwin C, Ma Q, Wyszynski DF, Amirault Y, Farrell JJ, Bisbee A, Embury SH, Farrer LA, Steinberg MH. Association of single nucleotide polymorphisms in klotho with priapism in sickle cell anaemia. Br J Haematol 2005 128 : 266 72.
16. Powars DR. Sickle cell anemia: beta s-gene-cluster haplotypes as prognostic indicators of vital organ failure. Semin Hematol 1991 28 : 202 8.
17. Wyszynski DF, Baldwin CT, Cleves MA, Amirault Y, Nolan VG, Farrell JJ, Bisbee A, Kutlar A, Farrer LA, Steinberg MH. Polymorphisms near a chromosome 6q QTL area are associated with modulation of fetal hemoglobin levels in sickle cell anemia. Cell Mol Biol (Noisy-le-Grand) 2004 50 : 23 33.
18. Elliott L, Ashley-Koch AE, De Castro L, Jonassaint J, Price J, Ataga KI, Levesque MC, Brice Weinberg J, Eckman JR, Orringer EP, Vance JM, Telen MJ. Genetic polymorphisms associated with priapism in sickle cell disease. Br J Haematol 2007 137 : 262 7.
19. Mourant A, Kopec A, Domaniewska-Sobczak K. Distribution of human blood groups and other polymorphisms. 2nd ed. London : Oxford University Press 1976.
20. Hadley TJ, Peiper SC. From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood 1997 89 : 3077 91.
21. Tournamille C, Colin Y, Cartron JP, Le Van Kim C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy- individuals. Nat Genet 1995 10 : 224 8.
22. Chaudhuri A, Nielsen S, Elkjaer ML, Zbrzezna V, Fang F, Pogo AO. Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of nonerythroid organs. Blood 1997 89 : 701 12.
23. Hadley TJ, Lu ZH, Wasniowska K, Martin AW, Peiper SC, Hesselgesser J, Horuk R. Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen. J Clin Invest 1994 94 : 985 91.
24. Peiper SC, Wang ZX, Neote K, Martin AW, Showell HJ, Conklyn MJ, Ogborne K, Hadley TJ, Lu Z, Hesselgesser J, Horuk R. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 1995 181 : 1311 7.
25. Issitt PD, Anstee DJ. Applied blood group serology. 4th ed. Durham : Montgomery Scientific Publications 1998.
26. Segerer S, Alpers CE. Chemokines and chemokine receptors in renal pathology. Curr Opin Nephrol Hypertens 2003 12 : 243 9.
27. Szabo MC, Soo KS, Zlotnik A, Schall TJ. Chemokine class differences in binding to the Duffy antigen-erythrocyte chemokine receptor. J Biol Chem 1995 270 : 25348 51.
28. Neote K, Darbonne W, Ogez J, Horuk R, Schall TJ. Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 1993 268 : 12247 9.
29. Horuk R, Colby TJ, Darbonne WC, Schall TJ, Neote K. The human erythrocyte inflammatory peptide (chemokine) receptor. Biochemical characterization, solubilization, and development of a binding assay for the soluble receptor. Biochemistry 1993 32 : 5733 8.
30. Rot A. Contribution of Duffy antigen to chemokine function. Cytokine Growth Factor Rev 2005 16 : 687 94.
31. Darbonne WC, Rice GC, Mohler MA, Apple T, Hébert CA, Valente AJ, Baker JB. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 1991 88 : 1362 9.
32. Duits AJ, Schnog JB, Lard LR, Saleh AW, Rojer RA. Elevated IL-8 levels during sickle cell crisis. Eur J Haematol 1998 61 : 302 5.
33. Kumar A, Eckmam JR, Swerlick RA, Wick TM. Phorbol ester stimulation increases sickle erythrocyte adherence to endothelium: a novel pathway involving alpha 4 beta 1 integrin receptors on sickle reticulocytes and fibronectin. Blood 1996 88 : 4348 58.
34. Abboud MR, Taylor EC, Habib D, Jackson SM, Xu F, Laver J, Ballas SK. Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell disease. Br J Haematol 2000 111 : 482 90.
35. Gil KM, Abrams MR, Phillips G, Keefe FJ. Sickle cell disease pain: relation of coping strategies to adjustment. J Consult Clin Psychol 1989 57 : 725 31.
36. Gil KM, Abrams MR, Phillips G, Williams DA. Sickle cell disease pain: 2. Predicting health care use and activity level at 9-month follow-up. J Consult Clin Psychol 1992 60 : 267 73.
37. Wison Schaeffer JJ, Gil KM, Burchinal M, Kramer KD, Nash KB, Orringer E, Strayhorn D. Depression, disease severity, and sickle cell disease. J Behav Med 1999 22 : 115 26.
38. Eyler CE, Telen MJ. The Lutheran glycoprotein: a multifunctional adhesion receptor. Transfusion 2006 46 : 668 77.
39. Zennadi R, Hines PC, De Castro LM, Cartron JP, Parise LV, Telen MJ. Epinephrine acts through erythroid signaling pathways to activate sickle cell adhesion to endothelium via LW-alphavbeta3 interactions. Blood 2004 104 : 3774 81.
40. Schnog JB, Keli SO, Pieters RA, Rojer RA, Duits AJ. Duffy phenotype does not influence the clinical severity of sickle cell disease. Clin Immunol 2000 96 : 264 8.
41. Powars DR, Elliott-Mills DD, Chan L, Niland J, Hiti AL, Opas LM, Johnson C. Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med 1991 115 : 614 20.
42. Akalin E, Neylan JF. The influence of Duffy blood group on renal allograft outcome in African Americans. Transplantation 2003 75 : 1496 500.
43. Kinney TR, Sleeper LA, Wang WC, Zimmerman RA, Pegelow CH, Ohene-Frempong K, Wethers DL, Bello JA, Vichinsky EP, Moser FG, Gallagher DM, DeBaun MR, Platt OS, Miller ST. Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The cooperative study of sickle cell disease. Pediatrics 1999 103 : 640 5.
44. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998 91 : 288 94.
45. Castro O, Brambilla DJ, Thorington B, Reindorf CA, Scott RB, Gillette P, Vera JC, Levy PS. The acute chest syndrome in sickle cell disease: incidence and risk factors. The cooperative study of sickle cell disease. Blood 1994 84 : 643 9.
46. Hsu LL, Champion HC, Campbell-Lee SA, Bivalacqua TJ, Manci EA, Diwan BA, Schimel DM, Cochard AE, Wang X, Schechter AN, Noguchi CT, Gladwin MT. Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood 2007 109 : 3088 98.